Skip to main content
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. — Investor Relations & Filings

Ticker · NERV ISIN · US6033802058 LEI · 54930017PANCHC5LYH79 US Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2014-04-09 Regulatory Filings
Country US United States of America
Listing US NERV

About Minerva Neurosciences, Inc.

https://www.minervaneurosciences.com/

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a detailed letter from a law firm to the SEC regarding comments on a Draft Registration Statement on Form S-1 for Minerva Neurosciences, Inc. It discusses responses to SEC comments on the registration statement, including risk factors, business descriptions, clinical trials, and financial disclosures. The Form S-1 is a registration statement used for initial public offerings (IPOs) and other securities offerings. This document is not the registration statement itself but a correspondence addressing SEC comments and revisions to the registration statement. It is not an annual report, earnings release, or any other financial report. It is a regulatory filing related to the registration process and SEC review. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is a substantive regulatory correspondence, not a brief announcement or certification.
2014-04-09 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 100% confidence The document is a confidential draft submission to the SEC of a Form S-1 Registration Statement for Minerva Neurosciences, Inc. It includes details about the registration of securities under the Securities Act of 1933, indemnification of directors and officers, recent sales of unregistered securities, and exhibits related to the registration. The Form S-1 is a registration statement used for initial public offerings (IPOs) and other securities offerings, which is a capital raising filing. It is not an annual report, earnings release, or any other type of financial or governance report. The content clearly indicates it is a capital/financing update related to the registration and offering of securities.
2014-03-31 English
Regulatory Filings 2014
Regulatory Filings
2014-03-14 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm submitting a draft Registration Statement on Form S-1 confidentially to the SEC for review prior to public filing. It is not the Registration Statement itself, but a submission letter related to the registration process. The document is short (1149 characters) and does not contain financial data or report content. It is a regulatory filing related to securities registration, thus best classified under Regulatory Filings (RNS).
2014-02-14 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC) for Minerva Neurosciences, Inc. It is a preliminary prospectus related to an initial public offering (IPO) of common stock. The text includes details about the offering, underwriting, risk factors, use of proceeds, and company overview. This type of filing is a registration statement under the Securities Act of 1933, used to register securities for public sale. It is not an annual report, earnings release, or any other financial report but a capital markets filing related to financing and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2014-02-14 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.